Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response. | Cancer Commun (Lond) | 2023 | 37539769 | PubTator, text mining | PubMed |
| Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. | Front Immunol | 2023 | 37539053 | PubTator, text mining | PubMed |
| Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities. | Lipids Health Dis | 2023 | 37537607 | PubTator, text mining | PubMed |
| Spondyloarthropathies That Mimic Ankylosing Spondylitis: A Narrative Review. | Clin Med Insights Arthritis Musculoskelet Disord | 2023 | 37533960 | PubTator, text mining | PubMed |
| Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle. | Am J Respir Cell Mol Biol | 2023 | 37523713 | PubTator, text mining | PubMed |
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts. | Pharmaceuticals (Basel) | 2023 | 37513894 | PubTator, text mining | PubMed |
| Raspberry Leaves and Extracts-Molecular Mechanism of Action and Its Effectiveness on Human Cervical Ripening and the Induction of Labor. | Nutrients | 2023 | 37513625 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers. | Int J Mol Sci | 2023 | 37511475 | PubTator, text mining | PubMed |
| Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host-Pathogen Interactions. | Biomolecules | 2023 | 37509095 | PubTator, text mining | PubMed |
| Editorial: Reviews in Psychiatry 2022: Schizophrenia. | Front Psychiatry | 2023 | 37502818 | PubTator, text mining | PubMed |
| Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data. | J Bone Oncol | 2023 | 37501717 | PubTator, text mining | PubMed |
| Liquid biopsies for cancer: From bench to clinic. | MedComm (2020) | 2023 | 37492785 | PubTator, text mining | PubMed |
| Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis. | Stem Cell Res Ther | 2023 | 37488601 | PubTator, text mining | PubMed |
| Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. | Comput Struct Biotechnol J | 2023 | 37484490 | PubTator, text mining | PubMed |
| Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments. | Heliyon | 2023 | 37484418 | PubTator, text mining | PubMed |
| Single hormone or synthetic agonist induces Gs/Gi coupling selectivity of EP receptors via distinct binding modes and propagating paths. | Proc Natl Acad Sci U S A | 2023 | 37478163 | PubTator, text mining | PubMed |
| MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target. | Front Immunol | 2023 | 37465670 | PubTator, text mining | PubMed |
| Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis. | J Med Chem | 2023 | 37458373 | PubTator, text mining | PubMed |
| PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. | Front Immunol | 2023 | 37457723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=20